Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NeuroD1-responsive DNA elements are specific regulatory DNA sequences (most often E-box motifs) to which the transcription factor NeuroD1 directly binds and modulates gene expression. These elements can be found at promoters and enhancers of neuronal development genes and play pivotal roles in facilitating the transcriptional and epigenetic changes that drive neuronal differentiation, reprogramming, and cell-fate commitment. NeuroD1 binding at these sites typically results in the loss of repressive chromatin marks (such as H3K27me3), gain of active marks (such as H3K27ac), increased chromatin accessibility, and ultimately the induction of neuron-specific gene programs; these changes can persist via epigenetic memory even after transient NeuroD1 expression. In general, “NeuroD1-responsive DNA element” denotes a class of cis-regulatory modules, not a protein or a classical therapeutic target. Therefore, “NeuroD1-responsive DNA element” itself is not a therapeutic target, but a mechanism for gene regulation. Clarification: The phrase “NeuroD1-responsive DNA elements” refers to DNA sequences and not a protein, receptor, or enzyme. It is not considered a therapeutic target per se. Instead, it denotes DNA motifs that mediate NeuroD1-driven gene regulation (not a typical druggable entity). If a drug targets this axis, it would more realistically target the NeuroD1 protein, not the DNA element itself. For work seeking canonical gene/protein targets, use "Neurogenic differentiation factor 1 (NeuroD1)" as the canonical protein target, not the DNA element.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NeuroD1-responsive DNA element.